IP Verse

Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma - EP3034073

The patent EP3034073 was granted to Chiesi Farmaceutici on Jun 12, 2019. The application was originally filed on Apr 16, 2008 under application number EP16152451A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3034073

CHIESI FARMACEUTICI
Application Number
EP16152451A
Filing Date
Apr 16, 2008
Status
Opposition Rejected
Sep 8, 2023
Grant Date
Jun 12, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LUPIN HEALTHCARE UKMar 12, 2020DEHNSWITHDRAWN
GILL JENNINGS & EVERYMar 11, 2020-ADMISSIBLE
TEVA PHARMACEUTICALSMar 4, 2020ELKINGTON AND FIFEWITHDRAWN

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO9964014
OPPOSITIONEP2146704
OPPOSITIONUS5972919
OPPOSITIONWO0189480
OPPOSITIONWO0228368
OPPOSITIONWO0228377
OPPOSITIONWO0228378
OPPOSITIONWO03074024
OPPOSITIONWO2008128685
OPPOSITIONWO9964014
SEARCHWO0228368
SEARCHWO0228377
SEARCHWO0228378
SEARCHWO2008128685
SEARCHWO9964014

Non-Patent Literature (NPL) Citations (46) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- ALBERTO PAPI, ET AL, "Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial", Lancet, (20130000), vol. 1, pages 23 - 31, XP055701982-
OPPOSITION- Alberto Papi, Et Al, "Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial", Lancet Resp Med, (20130101), vol. 1, pages 23 - 31, XP055701982-
OPPOSITION- anonymous, "Global initiative for Asthma", GINA Guidelines, (20060000), pages 1 - 109-
OPPOSITION- "A singel inhaler for asthma", Am J Crit Care Med, (20050000), vol. 171, pages 95 - 97, XP055710924-
OPPOSITION- BONNET-GONOD et al., "Beclometasone diproprionate/formoterol in a single inhaler improves lung function and clinically meaningful outcomes in moderate to severe asthma", 16th Annual Congress of the European Respiratory Society, (20060902), URL: https://www.ers-education.org/events/international-congress/munich-2006.aspx?idParent=6258-
OPPOSITION- D'URZO, "Inhaled Glucocorticosteroid and Long-Acting BETA2-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy A Paradigm Shift in Asthma Management", Treat. Respir. Med., (20060000), vol. 5, no. 6, pages 385 - 391, XP055708062-
OPPOSITION- Fujian Song, "What is indirect comparison? Fujian Song", Hayward Medical Communications, (20090101), pages 1 - 6, Hayward Medical Communications,, URL: http://www.bandolier.org.uk/painres/download/whatis/What_is_ind_comp.pdf, (20200608), XP055701986-
OPPOSITION- "Global Initiative for Asthma Management and Prevention", Global Initiative for Asthma Management and Prevention, (20060000), XP055710933-
OPPOSITION- "Inhaled Glucocorticosteroid and Long-Acting ~2-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy", Treat Respir Med., (20060000), vol. 5, no. 6, pages 385 - 391, XP055708062-
OPPOSITION- New Symbicort single inhaler asthma treatment gives much better asthma control, (20050523), URL: http://www.news-medical.net/news/ 2005/05/23 /10342.aspx, XP055336620-
OPPOSITION- O'BYRNE et al., "Pharmacological management of mild or moderate persistent asthma", Lancet, (20060000), vol. 368, pages 794 - 803, XP027947089-
OPPOSITION- PAPI et al., "Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial", Lancet Respir Med., (20130300), vol. 1, pages 23 - 31, XP055701982-
OPPOSITION- PICCINNO et al., "P1815 - Tolerability of high cumulative doses of a new fixed combination of beclomethasone dipropionate/formoterol in asthmatic patients", 16th Annual Congress of the European Respiratory Society, (20060902), page 316s, XP055708054-
OPPOSITION- Summary of product characteristics (SmPC) of Fostair 100/6 solution-
OPPOSITION- Summary of product characteristics (SmPC) of Symbicort Turbohaler 100/6 inhalation powder-
OPPOSITION- Razzetti, R. Bergamaschi, M. Villetti, G. Bolzoni, P. Civelli, M. Berti, F. Rossoni, G., "Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung", PHARMACOLOGICAL RESEARCH., ACADEMIC PRESS, LONDON., GB, GB, (20070413), vol. 55, no. 5, doi:10.1016/j.phrs.2007.01.018, ISSN 1043-6618, pages 426 - 432, XP022021221
OPPOSITION- Singh, D. ; Piccinno, A. ; Borrill, Z. ; Poli, G. ; Acerbi, D. ; Meuleners, L. ; Woodcock, A., "Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients", Pulmornary Pharmacology & Therapeutics, Academic Press, GB, GB, (20080601), vol. 21, no. 3, doi:10.1016/j.pupt.2008.01.001, ISSN 1094-5539, pages 551 - 557, XP022649868
OPPOSITION- Hak-Kim Chan, Chew Nora Y.K., "Novel alternative methods for the delivery of drugs for the treatment of asthma", Advanced Drug Delivery Reviews, Elsevier, (20030701), vol. 55, no. 7, doi:10.1016/S0169-409X(03)00078-4, ISSN 0169409X, pages 793 - 805, XP055075721
OPPOSITION- D. Ganderton, D. Lewis, R. Davies, B. Meakin, G. Brambilla, T. Church, "Modulite®: a means of designing the aerosols generated by pressurized metered dose inhalers", RESPIRATORY MEDICINE, BAILLIERE TINDALL, LONDON, GB, GB, (20020801), vol. 96, doi:10.1016/S0954-6111(02)80018-X, ISSN 0954-6111, pages S3 - S8, XP055702001
OPPOSITION- Woodcock, "Moulite technology pharmacodynamic and pharmacokinetic implications", Respiratory Medicine, (20020000), vol. 96, no. D, pages S9 - S15, XP055710930
OPPOSITION- Bousquet et al, "clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite)", Respiratory Medicine, (20020000), vol. 96, pages S17 - S27, XP55710925
OPPOSITION- Boonsawat W et al, "Formoterol (OXIS®) Turbuhaler® as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma", Respiratory Medicine, (20030000), vol. 97, pages 1067 - 1074, XP055336611
OPPOSITION- Jaro Ankerst, Gunnar Ankerst, Eva Persson, Weibull, "Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma", Pulmonary Pharmacology & Therapeutics, Academic Press, (20030601), vol. 16, no. 3, doi:10.1016/S1094-5539(03)00004-X, ISSN 10945539, pages 147 - 151, XP055156713
OPPOSITION- BOUROS D ET AL, "Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma.", EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society, GB, GB, (19990901), vol. 14, no. 3, doi:10.1034/j.1399-3003.1999.14c24.x, ISSN 0903-1936, pages 627 - 632, XP002449946
OPPOSITION- "budesonide/ formoterol combination therapy as both maintenance and reliever medication in asthma", Am J Respir Crit Care Med., (20050000), vol. 171, pages 129 - 136, XP055122196
OPPOSITION- O'BYRNE et al., "Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma", Am J Respir Crit Care Med, (20050000), vol. 171, pages 129 - 136, XP055122196
OPPOSITION- Paul M. O'byrne, Bisgaard Hans, Godard Philippe P., Pistolesi Massimo, Palmqvist Mona, Zhu Yuanjue, Ekstr�m Tommy, Bateman Eric D., "Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma", American Journal of Respiratory and Critical Care Medicine, (20050115), vol. 171, no. 2, doi:10.1164/rccm.200407-884OC, ISSN 1073449X, pages 129 - 136, XP055122196
OPPOSITION- Barnes P J, "Scientific rationale for using a single inhaler for asthma control", Eur Respir J, (20070301), vol. 29, pages 587 - 595, XP055337805
OPPOSITION- BARNES, "Scientific rationale for using a single inhaler for asthma control", Eur. Respir J, (20070000), vol. 29, pages 587 - 595, XP055337805
OPPOSITION- P. J. Barnes, "Scientific rationale for using a single inhaler for asthma control", EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society, GB, GB, (20070301), vol. 29, no. 3, doi:10.1183/09031936.00080306, ISSN 0903-1936, pages 587 - 595, XP055337805
OPPOSITION- A. Papi, P. L. Paggiaro, G. Nicolini, A. M. Vignola, L. M. Fabbri, "Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma", EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society, GB, GB, vol. 29, no. 4, doi:10.1183/09031936.00095906, ISSN 0903-1936, pages 682 - 689, XP055255561
OPPOSITION- "Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma", Eur Respir J 2007, (20061115), vol. 29, pages 682 - 689, XP055255561
OPPOSITION- LEONARDO M. FABBRI, "Beclomethasone/Formoterol vs Budesonide/Formoterol Combination Therapy in Asthma", ERJ Express, (20061115), XP055255561
OPPOSITION- Van Der Palen et al, "Multiple inhalers confuse asthma patients", Eur Respir J, (19990000), vol. 14, pages 1034 - 1037, XP055337800
OPPOSITION- Sabina A Antoniu, "Formoterol as a rescue medication for asthma", Expert Opin. Pharmacother, (20060000), vol. 7, no. 17, pages 2439 - 2441, XP055336601
OPPOSITION- DHILLON et al., "Beclometasone Dipropionate/Formoterol: In an HFA-Propelled Pressurised Metered-Dose Inhaler", Drugs, (20060000), vol. 66, no. 11, pages 1475 - 1483, XP055478782
OPPOSITION- Sohita Dhillon, Gillian M Keating, "Beclometasone Dipropionate/Formoterol: In an HFA-Propelled Pressurised Metered-Dose Inhaler", Drugs, Adis International, Cham, Cham, doi:10.2165/00003495-200666110-00005, (20060101), pages 1475 - 1483, URL: http://download.xuebalib.com/xuebalib.com.23467.pdf, XP055478782
OPPOSITION- BARNES et al., "Beclometasone Dipropionate/Formoterol: In an HFA-Propelled Pressurised Metered-Dose Inhaler a viewpoint by Peter J. Barnes", Drugs, (20060000), vol. 66, no. 11, pages 1484 - 1485, XP055701994
OPPOSITION- "Beclometasone Dipropionate/Formoterol: In an HFA-Propelled Pressurised Metered-Dose Inhaler a viewpoint by", Drugs, (20060000), vol. 66, pages 1475 - 1483, XP055701994
OPPOSITION- Peter J Barnes, "Beclometasone Dipropionate/Formoterol: In an HFA-Propelled Pressurised Metered-Dose Inhaler a viewpoint by Peter J. Barnes", Drugs, (20060101), vol. 66, no. 11, pages 1484 - 1485, XP055701994
SEARCH- RAZZETTI ET AL, "Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, (20070413), vol. 55, no. 5, ISSN 1043-6618, pages 426 - 432, XP022021221 [A] 1 * abstract *
SEARCH- SINGH D ET AL, "Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients", PULMORNARY PHARMACOLOGY & THERAPEUTICS, ACADEMIC PRESS, GB, vol. 21, no. 3, doi:10.1016/J.PUPT.2008.01.001, ISSN 1094-5539, (20080601), pages 551 - 557, (20080119), XP022649868 [T] * the whole document * * abstract * * page 225; table 3 *
SEARCH- JARO ANKERST ET AL, "Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma", PULMONARY PHARMACOLOGY & THERAPEUTICS, (20030601), vol. 16, no. 3, doi:10.1016/S1094-5539(03)00004-X, ISSN 1094-5539, pages 147 - 151, XP055156713 [A] 1 * the whole document * * abstract * * page 150; table 2 * * page 151, column 1, paragraph 2 *
SEARCH- BOUROS D ET AL, "Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma.", THE EUROPEAN RESPIRATORY JOURNAL : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR CLINICAL RESPIRATORY PHYSIOLOGY SEP 1999, (199909), vol. 14, no. 3, ISSN 0903-1936, pages 627 - 632, XP002449946 [A] 1 * abstract *
SEARCH- PAUL M. O'BYRNE ET AL, "Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (20050115), vol. 171, no. 2, doi:10.1164/rccm.200407-884OC, ISSN 1073-449X, pages 129 - 136, XP055122196 [A] 1
SEARCH- A. PAPI ET AL, "Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma", EUROPEAN RESPIRATORY JOURNAL., DK, (20070124), vol. 29, no. 4, doi:10.1183/09031936.00095906, ISSN 0903-1936, pages 682 - 689, XP055255561 [A] 1 * abstract * * page 688, column 1, paragraph 4 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents